The psychopharmacology of European herbs with cognition-enhancing properties.

Extensive research suggests that a number of plant-derived chemicals and traditional Oriental herbal remedies possess cognition-enhancing properties. Widely used current treatments for dementia include extracts of Ginkgo biloba and several alkaloidal, and therefore toxic, plant-derived cholinergic agents. Several non-toxic, European herbal species have pan-cultural traditions as treatments for cognitive deficits, including those associated with ageing. To date they have not received research interest commensurate with their potential utility. Particularly promising candidate species include sage (Salvia lavandulaefolia/officinalis), Lemon balm (Melissa officinalis) and rosemary (Rosmarinus officinalis). In the case of sage, extracts possess anti-oxidant, estrogenic, and anti-inflammatory properties, and specifically inhibit butyryl- and acetyl-cholinesterase. Acute administration has also been found to reliably improve mnemonic performance in healthy young and elderly cohorts, whilst a chronic regime has been shown to attenuate cognitive declines in sufferers from Alzheimer's disease. In the case of Melissa officinalis, extracts have, most notably, been shown to bind directly to both nicotinic and muscarinic receptors in human brain tissue. This property has been shown to vary with extraction method and strain. Robust anxiolytic effects have also been demonstrated following acute administration to healthy humans, with mnemonic enhancement restricted to an extract with high cholinergic binding properties. Chronic regimes of aromatherapy and essential oil respectively have also been shown to reduce agitation and attenuate cognitive declines in sufferers from dementia. Given the side effect profile of prescribed cholinesterase inhibitors, and a current lack of a well tolerated nicotinic receptor agonist, these herbal treatments may well provide effective and well-tolerated treatments for dementia, either alone, in combination, or as an adjunct to conventional treatments.

[1]  L. Parnetti,et al.  Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? , 2001, Mechanisms of Ageing and Development.

[2]  J. Shepherd Effects of estrogen on congnition mood, and degenerative brain diseases. , 2001, Journal of the American Pharmaceutical Association.

[3]  Huafu Wang,et al.  Determination of rosmarinic acid and caffeic acid in aromatic herbs by HPLC , 2004 .

[4]  H. Kameoka,et al.  Inhibition of Acetylcholinesterase Activity by Monoterpenoids with a p-Menthane Skeleton , 1997 .

[5]  N. Perry,et al.  In‐vitro Inhibition of Human Erythrocyte Acetylcholinesterase by Salvia lavandulaefolia Essential Oil and Constituent Terpenes , 2000, The Journal of pharmacy and pharmacology.

[6]  R. Jankov,et al.  Carnosic acid 12-methyl ether-γ-lactone, a ferruginol-type diterpene from Salvia officinalis , 1992 .

[7]  E D Levin,et al.  Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory. , 2002, Neuroscience.

[8]  S. Stahl Cholinesterase inhibitors for Alzheimer's disease. , 1998, Hospital practice.

[9]  E. Perry,et al.  Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. , 2002, The Journal of clinical psychiatry.

[10]  D. Kennedy,et al.  Attenuation of Laboratory-Induced Stress in Humans After Acute Administration of Melissa officinalis (Lemon Balm) , 2004, Psychosomatic medicine.

[11]  H. Kameoka,et al.  Inhibition of Acetylcholinesterase Activity by Essential Oils of Mentha Species , 1998 .

[12]  E. Putievsky,et al.  The influence of season and harvest frequency on essential oil and herbal yields from a pure clone of sage (Salvia officinalis) grown under cultivated conditions , 1986 .

[13]  J. Quillfeldt,et al.  Role of hippocampal M1 and M4 muscarinic receptor subtypes in memory consolidation in the rat , 2003, Pharmacology Biochemistry and Behavior.

[14]  A. Cerny,et al.  Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double-blind, placebo-controlled, multicentre study) , 1999 .

[15]  H. Haraguchi,et al.  Flavonoids in Rosmarinus officinalis leaves. , 1994, Phytochemistry.

[16]  A. Ghannadi,et al.  Relaxant effect of essential oil of Melissa officinalis and citral on rat ileum contractions. , 2003, Fitoterapia.

[17]  A. Blokland Acetylcholine: a neurotransmitter for learning and memory? , 1995, Brain Research Reviews.

[18]  M. Diego,et al.  Aromatherapy positively affects mood, EEG patterns of alertness and math computations. , 1998, The International journal of neuroscience.

[19]  Turan M. Itil,et al.  A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia , 1997 .

[20]  V. Jordan Designer estrogens. , 1998, Scientific American.

[21]  M. Thorsen,et al.  Quantitative determination of phenolic diterpenes in rosemary extracts. Aspects of accurate quantification. , 2003, Journal of chromatography. A.

[22]  Richard Evans Schultes,et al.  Oriental Materia Medica: A Concise Guide , 2008, Economic Botany.

[23]  H. J. Arnold,et al.  Contribution to the Study of the Essential Oils from Three Species of Salvia Growing Wild in the Eastern Mediterranean Region , 1992 .

[24]  S. Ruggieri,et al.  Antioxidant properties of Mediterranean spices compared with common food additives. , 2001, Journal of food protection.

[25]  J. Gorman New molecular targets for antianxiety interventions. , 2003, The Journal of clinical psychiatry.

[26]  V. Henderson Estrogen, cognition, and a woman's risk of Alzheimer's disease. , 1997, The American journal of medicine.

[27]  J. Lamaison,et al.  [Medicinal Lamiaceae with antioxidant properties, a potential source of rosmarinic acid]. , 1991, Pharmaceutica acta Helvetiae.

[28]  E. Perry,et al.  Medicinal Plant Extracts for the Treatment of Dementia , 2000 .

[29]  A. Schatzberg,et al.  A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. , 1997, JAMA.

[30]  H. Boon,et al.  Herbal remedies in psychiatric practice. , 1998, Archives of general psychiatry.

[31]  Keith Wesnes,et al.  AROMAS OF ROSEMARY AND LAVENDER ESSENTIAL OILS DIFFERENTIALLY AFFECT COGNITION AND MOOD IN HEALTHY ADULTS , 2003, The International journal of neuroscience.

[32]  J. D. del Campo,et al.  Antimicrobial effect of rosemary extracts. , 2000, Journal of food protection.

[33]  G. Carey,et al.  SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals. , 2001, European journal of pharmacology.

[34]  M. Villarroya,et al.  New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease. , 2004, Current pharmaceutical design.

[35]  N. Perry,et al.  In‐vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease , 2001, The Journal of pharmacy and pharmacology.

[36]  P. Andrade,et al.  Phenolic antioxidant compounds produced by in vitro shoots of sage (Salvia officinalis L.) , 2002 .

[37]  R. Strange A history of herbal plants , 1977 .

[38]  Douglas Walker,et al.  Inflammation and Alzheimer's disease pathogenesis , 1996, Neurobiology of Aging.

[39]  E. Levin,et al.  Hippocampal α7 and α4β2 nicotinic receptors and working memory , 2002, Neuroscience.

[40]  G. Morgante,et al.  [Treatment of neurovegetative menopausal symptoms with a phytotherapeutic agent]. , 1998, Minerva ginecologica.

[41]  Georges Chapouthier,et al.  GABA-A receptor complex and memory processes. , 2002, Current topics in medicinal chemistry.

[42]  E. Perry,et al.  CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. , 2000, Journal of ethnopharmacology.

[43]  K. Yaffe,et al.  Hormone replacement therapy to maintain cognitive function in women with dementia. , 2002, The Cochrane database of systematic reviews.

[44]  D. Mantle,et al.  Comparison of relative antioxidant activities of British medicinal plant species in vitro. , 2000, Journal of ethnopharmacology.

[45]  E. Perry,et al.  Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo. , 2002, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[46]  D. Rivera,et al.  The Botany, History And Traditional Uses Of Three-Lobed Sage (Salvia Fruticosa Miller) (Labiatae) , 1994, Economic Botany.

[47]  J. Hohmann,et al.  Protective Effects of the Aerial Parts of Salvia officinalis, Melissa officinalis and Lavandula angustifolia and their Constituents against Enzyme-Dependent and Enzyme-Independent Lipid Peroxidation , 1999, Planta medica.

[48]  K. Yaffe,et al.  Hormone replacement therapy for cognitive function in postmenopausal women (Cochrane Review) , 2002 .

[49]  J. Goodier Bartram’s Encyclopedia of Herbal Medicine , 1999 .

[50]  E. Perry,et al.  Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers , 2003, Pharmacology Biochemistry and Behavior.

[51]  E. Perry,et al.  Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil , 2003, Pharmacology Biochemistry and Behavior.

[52]  J. Lamaison,et al.  The aromatic and polyphenolic composition of lemon balm (Melissa officinalis L. subsp. officinalis) tea , 1998 .

[53]  R. Soulimani,et al.  Neurotropic action of the hydroalcoholic extract of Melissa officinalis in the mouse. , 1991, Planta medica.

[54]  J. Philpott,et al.  Herbal medicine past and present , 1990 .

[55]  Anthony Gamst,et al.  Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial , 2000 .

[56]  Peter F Surai,et al.  Evaluation in vitro of plant essential oils as natural antioxidants , 1995 .

[57]  L. Foo,et al.  Rosmarinic acid derivatives from Salvia officinalis , 1999 .

[58]  P. Fernández-Zurbano,et al.  Capillary electrophoretic separation of phenolic diterpenes from rosemary. , 2002, Journal of chromatography. A.

[59]  Y. Ohtake,et al.  A New Antioxidative 1,3-Benzodioxole from Melissa officinalis , 1998 .

[60]  Hsu Hong-Yen,et al.  Oriental Materia Medica: A Concise Guide , 1986 .

[61]  M. Carreiras,et al.  Recent approaches to novel anti-Alzheimer therapy. , 2004, Current pharmaceutical design.

[62]  H. Gertz,et al.  Review about Ginkgo biloba special extract EGb 761 (Ginkgo). , 2003, Current pharmaceutical design.

[63]  E. Perry,et al.  Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial , 2003, Pharmacology Biochemistry and Behavior.

[64]  T. Myhrer Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks , 2003, Brain Research Reviews.

[65]  E. Perry,et al.  Medicinal Plants and Alzheimer's Disease: from Ethnobotany to Phytotherapy ** , 1999, The Journal of pharmacy and pharmacology.

[66]  Mohammad Reza Mohammadi,et al.  Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomised, placebo controlled trial , 2003, Journal of neurology, neurosurgery, and psychiatry.

[67]  P. Aisen Inflammation and Alzheimer disease , 1996, Molecular and chemical neuropathology.

[68]  U. Justesen,et al.  Composition of flavonoids in fresh herbs and calculation of flavonoid intake by use of herbs in traditional Danish dishes , 2001 .

[69]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[70]  M. Simmonds,et al.  Rosmarinic acid. , 2003, Phytochemistry.

[71]  E. Perry,et al.  EUROPEAN HERBS WITH CHOLINERGIC ACTIVITIES: POTENTIAL IN DEMENTIA THERAPY , 1996 .

[72]  Mohammad Reza Mohammadi,et al.  Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial , 2003, Journal of clinical pharmacy and therapeutics.

[73]  E. Okello,et al.  Butyryl‐ and acetyl‐cholinesterase inhibitory activities in essential oils of Salvia species and their constituents , 2004, Phytotherapy research : PTR.

[74]  E. Perry,et al.  Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm) , 2002, Pharmacology Biochemistry and Behavior.